Cinque Terra News Today

For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and officials are pushing drugmakers to study lower doses early in the research process.

For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary.

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have

The U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose

After advocacy from patients and doctors, the FDA is now pushing drugmakers to find the lowest effective dose of cancer drugs to reduce harsh side effects.

Through Project Optimus, the US Food and Drug Administration is encouraging drug developers to conduct more head-to-head dosing comparisons. | Health